New eczema drug enters first human safety trials
Symptom relief
Recruiting now
This early-stage study tests a new drug called ATTO-3712 in healthy adults and people with atopic dermatitis (eczema). The main goal is to check if the drug is safe and how the body processes it. Participants will receive either the drug or a placebo and will be monitored through…
Phase: PHASE1 • Sponsor: Attovia Therapeutics Inc • Aim: Symptom relief
Last updated May 17, 2026 02:55 UTC